Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Ong CWM, Migliori GB, Raviglione M, MacGregor-Skinner G, Sotgiu G, Alffenaar JW, Tiberi S, Adlhoch C, Alonzi T, Archuleta S, Brusin S, Cambau E, Capobianchi MR, Castilletti C, Centis R, Cirillo DM, D'Ambrosio L, Delogu G, Esposito SMR, Figueroa J, Friedland JS, Ho BCH, Ippolito G, Jankovic M, Kim HY, Rosales Klintz S, Ködmön C, Lalle E, Leo YS, Leung CC, Märtson AG, Melazzini MG, Najafi Fard S, Penttinen P, Petrone L, Petruccioli E, Pontali E, Saderi L, Santin M, Spanevello A, van Crevel R, van der Werf MJ, Visca D, Viveiros M, Zellweger JP, Zumla A, Goletti D. Ong CWM, et al. Among authors: d ambrosio l, visca d. Eur Respir J. 2020 Oct 1;56(4):2001727. doi: 10.1183/13993003.01727-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32586885 Free PMC article. Review.
Classifying new anti-tuberculosis drugs: rationale and future perspectives.
Tiberi S, Scardigli A, Centis R, D'Ambrosio L, Muñoz-Torrico M, Salazar-Lezama MÁ, Spanevello A, Visca D, Zumla A, Migliori GB, Caminero Luna JA. Tiberi S, et al. Among authors: d ambrosio l, visca d. Int J Infect Dis. 2017 Mar;56:181-184. doi: 10.1016/j.ijid.2016.10.026. Epub 2016 Nov 3. Int J Infect Dis. 2017. PMID: 27818361 Free article.
World TB Day 2017: Strengthening the fight against TB.
Solovic I, Centis R, D'Ambrosio L, Visca D, Battista Migliori G. Solovic I, et al. Among authors: d ambrosio l, visca d. Presse Med. 2017 Mar;46(2 Pt 2):e1-e4. doi: 10.1016/j.lpm.2017.02.002. Presse Med. 2017. PMID: 28336002 No abstract available.
Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico.
Munoz-Torrico M, Salazar MA, Millán MJM, Martínez Orozco JA, Narvaez Diaz LA, Segura Del Pilar M, Visca D, D'Ambrosio L, Centis R, Migliori GB. Munoz-Torrico M, et al. Among authors: d ambrosio l, visca d. Eur Respir J. 2018 Mar 22;51(3):1702267. doi: 10.1183/13993003.02267-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29567721 Free article. No abstract available.
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.
Silva DR, Dalcolmo M, Tiberi S, Arbex MA, Munoz-Torrico M, Duarte R, D'Ambrosio L, Visca D, Rendon A, Gaga M, Zumla A, Migliori GB. Silva DR, et al. Among authors: d ambrosio l, visca d. J Bras Pneumol. 2018 Apr;44(2):153-160. doi: 10.1590/s1806-37562017000000436. J Bras Pneumol. 2018. PMID: 29791557 Free PMC article. Review.
Tuberculosis elimination: where are we now?
Matteelli A, Rendon A, Tiberi S, Al-Abri S, Voniatis C, Carvalho ACC, Centis R, D'Ambrosio L, Visca D, Spanevello A, Battista Migliori G. Matteelli A, et al. Among authors: d ambrosio l, visca d. Eur Respir Rev. 2018 Jun 13;27(148):180035. doi: 10.1183/16000617.0035-2018. Print 2018 Jun 30. Eur Respir Rev. 2018. PMID: 29898905 Free PMC article. Review.
124 results